These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27861784)

  • 21. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulatory effects of cannabinoids on brain neurotransmission.
    Cohen K; Weizman A; Weinstein A
    Eur J Neurosci; 2019 Aug; 50(3):2322-2345. PubMed ID: 30882962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.
    Gerra G; Zaimovic A; Gerra ML; Ciccocioppo R; Cippitelli A; Serpelloni G; Somaini L
    Recent Pat CNS Drug Discov; 2010 Jan; 5(1):46-52. PubMed ID: 19832688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic cannabinoid poisoning: A growing health concern.
    Phillips J; Lim F; Hsu R
    Nursing; 2016 Nov; 46(11):34-41. PubMed ID: 27673323
    [No Abstract]   [Full Text] [Related]  

  • 26. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
    Jensen B; Chen J; Furnish T; Wallace M
    Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
    Diao X; Huestis MA
    Clin Pharmacol Ther; 2017 Feb; 101(2):239-253. PubMed ID: 27727455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
    Bolognini D; Ross RA
    Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro.
    Young AP; Denovan-Wright EM
    Brain Behav Immun; 2022 Oct; 105():29-43. PubMed ID: 35764268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
    Bab I; Zimmer A; Melamed E
    Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic applications of cannabinoids.
    Maurya N; Velmurugan BK
    Chem Biol Interact; 2018 Sep; 293():77-88. PubMed ID: 30040916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR
    Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.
    McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA
    Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of cannabinoid receptor ligands: current status.
    Singh J; Budhiraja S
    Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis in cancer care.
    Abrams DI; Guzman M
    Clin Pharmacol Ther; 2015 Jun; 97(6):575-86. PubMed ID: 25777363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.